Carotid Artery Restenosis (CAR)
SPN | A280 |
PubMed | 25595635 |
Wiki | Restenosis |
Restenosis remains a major limitation of coronary angioplasty in spite of major advances in techniques and technology. When a stent is used and restenosis occurs, this is called in-stent restenosis or ISR. If it occurs following balloon angioplasty, this is called post-angioplasty restenosis or PARS. The diagnostic threshold for restenosis in both ISR or PARS is ≥50% stenosis. In cardiac procedures, balloon angioplasty has been associated with a high incidence of restenosis, with rates ranging from 25% to 50%, and the majority of these patients need further angioplasty within 6 months.
Organism species: Pan-species (General)
PRODUCT TYPE | CATALOG NO. | PRODUCT NAME | APPLICATIONS |
---|---|---|---|
Proteins | N/A | Recombinant Carotid Artery Restenosis (CAR) | Antigenic Transformation Customized Service Offer |
Antibodies | N/A | Monoclonal Antibody to Carotid Artery Restenosis (CAR) | Monoclonal Antibody Customized Service Offer |
N/A | Polyclonal Antibody to Carotid Artery Restenosis (CAR) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | N/A | CLIA Kit for Carotid Artery Restenosis (CAR) | CLIA Kit Customized Service Offer |
N/A | ELISA Kit for Carotid Artery Restenosis (CAR) | ELISA Kit Customized Service Offer |